Overview of FDA’s Fresh Herbs Sampling Findings
On July 26, 2024, the U.S. Food and Drug Administration (FDA) released a summary report detailing the results of a sampling assignment involving fresh basil, cilantro, and parsley. This initiative aimed to estimate the prevalence of Cyclospora cayetanensis, Salmonella spp., and Shiga toxin-producing Escherichia coli (STEC) in these herbs, as part of the FDA’s commitment to food safety.
Key Findings
Between September 2017 and September 2021, the FDA tested 1,383 samples of fresh basil, cilantro, and parsley. Here are the main results:
- Salmonella spp.: Detected in 17 out of 1,358 samples.
- C. cayetanensis: Found in 18 out of 812 samples.
- STEC: Detected in 1 out of 1,350 samples.
The FDA collaborated closely with firms to ensure the swift removal of contaminated products from the market. It’s important to note that the assignment’s timeline extended due to a nine-month pause during the COVID-19 pandemic.
Public Health Impact
Contamination of fresh herbs with Salmonella spp., C. cayetanensis, and STEC poses significant public health risks. From FY2000 through FY2016, cilantro was linked to at least three outbreaks in the U.S. Since 2017, there have been at least six additional outbreaks involving basil, cilantro, and parsley, resulting in over 1,200 illnesses and 80 hospitalizations. These findings underscore the importance of proactive measures to prevent contamination and protect public health.
Industry Compliance and Recommendations
In light of these findings, the FDA encourages the industry to comply with several key regulations:
- Produce Safety Rule
- Preventive Controls for Human Food Rule
- FSMA Final Rule on Requirements for Additional Traceability Records for Certain Foods
Importers of fresh herbs should also ensure compliance with the Foreign Supplier Verification Programs Rule.
Future Directions
This assignment marks the FDA’s first large-scale field activity focused on fresh basil, cilantro, and parsley. The collected data will inform the agency’s guidance, update program priorities, and shape future sampling assignments and surveillance inspections. The FDA will continue to sample these herbs for pathogens as necessary to safeguard consumers.
Need Help Navigating These Updates?
Garg Law is here to assist you with understanding and complying with these FDA updates. Our expertise in FDA regulations ensures you stay compliant and informed.
Contact Us today for tailored legal advice and support.
Read the full FDA article here.